1. Home
  2. STAG vs GKOS Comparison

STAG vs GKOS Comparison

Compare STAG & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stag Industrial Inc.

STAG

Stag Industrial Inc.

HOLD

Current Price

$39.60

Market Cap

7.3B

Sector

Real Estate

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$119.43

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAG
GKOS
Founded
2010
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
6.0B
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
STAG
GKOS
Price
$39.60
$119.43
Analyst Decision
Hold
Strong Buy
Analyst Count
9
12
Target Price
$39.56
$126.92
AVG Volume (30 Days)
989.9K
551.7K
Earning Date
04-28-2026
04-29-2026
Dividend Yield
3.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$845,184,000.00
$507,442,000.00
Revenue This Year
$8.59
$23.32
Revenue Next Year
$9.28
$27.43
P/E Ratio
N/A
N/A
Revenue Growth
10.14
32.33
52 Week Low
$31.79
$73.16
52 Week High
$39.99
$130.23

Technical Indicators

Market Signals
Indicator
STAG
GKOS
Relative Strength Index (RSI) 61.46 54.53
Support Level $36.80 $104.72
Resistance Level $39.79 $123.09
Average True Range (ATR) 0.63 3.95
MACD 0.13 -0.18
Stochastic Oscillator 82.90 35.41

Price Performance

Historical Comparison
STAG
GKOS

About STAG Stag Industrial Inc.

Stag Industrial Inc is a REIT focused on the acquisition, ownership, development, and operation of industrial properties throughout the United States. Its platform is designed to (i) identify properties for acquisition that offer attractive returns across CBRE-EA Tier 1 industrial real estate markets, industries, and tenants, (ii) provide growth through the ownership of high-quality assets, property management and pursuit of acquisitions in an attractive opportunity set, and (iii) capitalize its business appropriately given the characteristics of its assets. The majority of its portfolio is single-tenant industrial properties throughout the United States. The company derives the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: